Latest

NCCN

Home NCCN

NCCN

NCCN Awards Grants to Investigators to Study Trifluridine & Tipiracil

March 14, 2019

Weill Cornell Investigator S. Rutherford Discusses Pilot Study for Use of Ribavirin in Follicular...

March 25, 2019

Dr. Patrick O’Neil, the Medical University of South Carolina

March 25, 2019

David Hyman, MD, Chief of the Early Drug Dev Services at Memorial Sloan Kettering...

March 25, 2019

MIT Alzheimer’s Research in Mice Could Hold Promise for Humans

March 25, 2019

TrialSite News is the only digital media dedicated 100% to transparent and open coverage of clinical research trial sites around the globe. Based in the Silicon Slopes in downtown Salt Lake City, Utah, we are founded by a team of experts in the clinical trials industry and dedicated to transparency, quality and clinical trial innovation.

307 West 200 South #5002
Salt Lake City, UT 84101
Contact us: admin@trialsitenews.com

Privacy Policy

Contact

© TrialSite News, Inc. All Rights Reserved

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site you consent to our use of cookies.Ok

Edit with Live CSS

Save
Write CSS OR LESS and hit save. CTRL + SPACE for auto-complete.

NCCN Awards Grants to Investigators to Study Trifluridine & Tipiracil

EDITOR PICKS

Weill Cornell Investigator S. Rutherford Discusses Pilot Study for Use of Ribavirin in Follicular...

Dr. Patrick O’Neil, the Medical University of South Carolina

David Hyman, MD, Chief of the Early Drug Dev Services at Memorial Sloan Kettering...

MIT Alzheimer’s Research in Mice Could Hold Promise for Humans